| Expression pattern: |
UP |
| Associated gene: |
- |
| Associated microRNA: |
miR-455-3p |
| Biological function: |
Promotes colorectal cancer cell proliferation, migration and invasion; promotes cell cycle entry; inhibits apoptosis. |
| Molecular mechanism: |
Acts as a miRNA sponge/ceRNA by directly binding miR-455-3p and suppressing its expression; validated with dual-luciferase reporter assay and rescue experiments using miR-455-3p mimic/inhibitor. |
| Biological pathway or process: |
proliferation (promotes); migration (promotes); invasion (promotes); apoptosis (inhibits); cell cycle (promotes); ceRNA regulation (promotes) |
| Detected method: |
Q
|
| Validation methods: |
RT-qPCR; Clinical Sample Validation; Bioinformatics Analysis; Luciferase Reporter Assay; Transfection; CCK8; Colony Formation Assay; Cell Cycle Assay; Annexin V/PI Flow Cytometry; Wound Healing Assay; Transwell Assay |
| Clinical significance: |
hsa_circRNA_102049 expression was associated with clinicopathological features of CRC patients (differentiation, TNM stage, lymphatic migration and invasion, histological classification) and may be a potential biomarker/therapeutic target. |
| Description: |
hsa_circRNA_102049 (alias hsa_circ_0043278, host gene TADA2A) is upregulated in colorectal cancer tissues and cell lines. It promotes CRC proliferation, cell-cycle progression, migration and invasion and inhibits apoptosis by sponging/binding miR-455-3p, supported by luciferase and rescue experiments. |
| Confidence score: |
0.6542 |